Blood Transfusion 2-2018 (March - April)
Original article
-
Genetic factors associated with iron storage in Australian blood donors
-
Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform
-
Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach
-
Transfusion-associated circulatory overload in adult, medical emergency patients with perspectives on early warning practice: a single-centre, clinical study
-
Platelet-, leucocyte- and red cell-derived microparticles in stored whole blood, with and without leucofiltration, with and without ionising radiation
-
Cost-utility and budget impact of methylene blue-treated plasma compared to quarantine plasma
-
Application of a clot-based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates
-
Effects of potassium adsorption filters on the removal of ammonia from blood products
-
Prevalence of antibodies to a new histo-blood system: the FORS system
-
Single-stranded DNA aptamer targeting and neutralization of anti-D alloantibody: a potential therapeutic strategy for haemolytic diseases caused by Rhesus alloantibody
-
Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies
-
Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre